linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Suzlon Energy Ltd.
 
Source DateBoard Meeting DateDetails
28 Jan 202605 Feb 2026 Quarterly Results
28 Oct 202504 Nov 2025 Quarterly Results
05 Aug 202512 Aug 2025 Quarterly Results
22 May 202529 May 2025 Audited Results
21 Jan 202528 Jan 2025 Quarterly Results
21 Oct 202428 Oct 2024532667 | Board Meeting Intimation for To, Inter Alia, Consider And Approve The Unaudited Financial Results Of The Company On Standalone And Consolidated Basis For The Quarter And Half Year Ended On 30Th September 2024. Board Meeting 0.30 MB XBRLSUZLON ENERGY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28-10-2024 ,inter alia, to consider and approve Unaudited Financial Results of the Company on Standalone and Consolidated basis for the quarter and half year ended on 30th September 2024
15 Jul 202422 Jul 2024 Quarterly Results
17 May 202424 May 2024 Quarterly Results
24 Jan 202431 Jan 2024 Quarterly Results
26 Oct 202302 Nov 2023 Quarterly Results
18 Jul 202325 Jul 2023 Quarterly Results
04 Jul 202307 Jul 2023 Inter alia, to consider and approve: 1. Capital raising by way of one or more or combination of permissible methods; and 2. Seeking approval of the shareholders, if required
23 May 202330 May 2023 Quarterly Results
21 Feb 202324 Feb 2023 Inter alia, to consider making of subsequent call(s) on the outstanding 240,00,00,000 (Two Hundred Forty Crores) partly paid-up equity shares of the Company.
01 Feb 202309 Feb 2023 Quarterly Results
02 Nov 202210 Nov 2022 Quarterly Results
21 Sep 202225 Sep 2022 Rights Issue
04 Aug 202210 Aug 2022 Quarterly Results Inter alia, to consider Various capital raising options for the Company, as the Board may deem appropriate
18 May 202225 May 2022 Audited Results
24 Feb 202227 Feb 2022 Inter alia, to consider and approve the issuance of securities of the Company to the lenders by way of preferential issue or private placement or any other method permissible in terms of the applicable regulations and as the Board may deem fit, subject to the approval of the shareholders
Page 1 of 5
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.